Sirolimus and FTY720: New approaches to transplant immunosuppression

被引:5
作者
Kahan, BD [1 ]
机构
[1] Univ Texas, Div Immunol & Organ Transplantat, Houston, TX 77030 USA
关键词
D O I
10.1016/S0041-1345(02)03472-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
引用
收藏
页码:2520 / 2522
页数:3
相关论文
共 7 条
[1]
A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function [J].
Hong, JC ;
Kahan, BD .
TRANSPLANTATION, 2001, 71 (09) :1320-1328
[2]
Kahan BD, 2000, TRANSPLANTATION, V69, pS132
[3]
Rapamycin: Clinical results and future opportunities [J].
Kahan, BD ;
Camardo, JS .
TRANSPLANTATION, 2001, 72 (07) :1181-1193
[4]
Median effect analysis of efficacy versus adverse effects of immunosuppressants [J].
Kahan, BD ;
Kramer, WG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (01) :74-81
[5]
TEDESCO H, 2001, AM J TRANSPLANTAT S1, V1, P243
[6]
Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine [J].
Troncoso, P ;
Stepkowski, SM ;
Wang, ME ;
Qu, XM ;
Chueh, SC ;
Clark, J ;
Kahan, BD .
TRANSPLANTATION, 1999, 67 (01) :145-151
[7]
Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus [J].
Wang, ME ;
Tejpal, N ;
Qu, XM ;
Yu, J ;
Okamoto, M ;
Stepkowski, SM ;
Kahan, BD .
TRANSPLANTATION, 1998, 65 (07) :899-905